Supernus Pharmaceuticals, Inc. (SUPN)
53.87
-0.40
(-0.74%)
USD |
NASDAQ |
Mar 06, 16:00
53.92
+0.05
(+0.09%)
After-Hours: 20:00
Supernus Pharmaceuticals SG&A Expense (TTM) : 485.56M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biogen, Inc. | 2.434B |
| BridgeBio Pharma, Inc. | 531.22M |
| Corcept Therapeutics, Inc. | 448.72M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Cytokinetics, Inc. | 284.27M |